Application

16206981 · ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER

Filed 2018-11-30 · Abandoned The official file ↗ · Art unit 1617 · Examiner Genevieve S Alley Typical · CPC A61K 31/485 · Spriaso LLC · Lipocine-Com

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

7.2 mo

to disposition 14.5 mo

Statutes raised

103

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.